← Eichor
Condition: Autologous Haemopoietic Stem Cell Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autologous Haemopoietic Stem Cell Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Phase 2 · 18 location(s) · Canadian Cancer Trials Group · NCT05180097A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · 270 location(s) · Janssen Research & Development, LLC · NCT05552222Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Tr
Phase 2 · 1 location(s) · University of Utah · NCT05405387Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · 117 location(s) · SWOG Cancer Research Network · NCT06022939A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplan
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06679829Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · 22 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04047628Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT06687772Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
Phase 1/Phase 2 · 1 location(s) · New York Medical College · NCT04491370Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT05706766Mozobil for Autologous Hematopoietic Stem Cell Transplantation
Phase 2 · 1 location(s) · Thomas Jefferson University · NCT07188090A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
Phase N/A · 13 location(s) · Takeda · NCT05100056Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in T
Phase 3 · 64 location(s) · Intergroupe Francophone du Myelome · NCT06918002PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Mult
NA · 6 location(s) · Centre Leon Berard · NCT05947136MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06377540Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · 35 location(s) · University Hospital Freiburg · NCT06830421High Heated Humidity in Stem Cell Transplant
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05358262ATLG Levels in Autologous HSCT for Multiple Sclerosis
Phase N/A · 1 location(s) · Ciceri Fabio · NCT07635693Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
Phase 2 · 1 location(s) · Stephan Grupp MD PhD · NCT05029336Autologous Stem Cell Transplant for Crohn's Disease
Phase 2 · 1 location(s) · Aaron Etra · NCT03219359Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT07365306The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
Phase 3 · 91 location(s) · University of Leeds · NCT03562169Low Dose Epcoritamab Plus GemOx in R/R DLBCL
Phase 2 · 1 location(s) · Hospital Universitario Dr. Jose E. Gonzalez · NCT07451652TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
EARLY_Phase 1 · 1 location(s) · City of Hope Medical Center · NCT04380831Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequenti
Phase 2 · 11 location(s) · SCRI Development Innovations, LLC · NCT06974786Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
Phase 1 · 3 location(s) · Baylor College of Medicine · NCT01555892Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemother
NA · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT05889585Auto Stem Cell Transplant for Lymphoma Patients
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03125642Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
NA · 1 location(s) · Noha Mohamed Sharafeldin · NCT05642884
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.